Turner-WarwickM. Epidemiology of nocturnal asthma. Am J Med. 1988;85:6-8.
2.
HaxhiuMARustCFBrooksCKcP. CNS determinants of sleep-related worsening of airway functions: implications for nocturnal asthma. Respir Physiol Neurobiol. 2006;151:1-30.
3.
KraftMMartinRJWilsonSDjukanovicRHolgateST. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am J Respir Crit Care Med. 1999;159:228-234.
4.
SzeflerSJAndoRCicuttoLCSursWHillMRMartinRJ. Plasma histamine, epinephrine, cortisol, and leukocyte beta-adrenergic receptors in nocturnal asthma. Clin Pharmacol Ther. 1991;49:59-68.
5.
KraftMViannaEMartinRJLeungDY. Nocturnal asthma is associated with reduced glucocorticoid receptor binding affinity and decreased steroid responsiveness at night. J Allergy Clin Immunol. 1999;103(1 pt 1):66-71.
6.
SutherlandEREllisonMCKraftMMartinRJ. Elevated serum melatonin is associated with the nocturnal worsening of asthma. J Allergy Clin Immunol. 2003;112:513-517.
7.
Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep. 1999;22:667-689.
8.
YoungTPaltaMDempseyJSkatrudJWeberSBadrS. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230-1235.
9.
StephensonR. Circadian rhythms and sleep-related breathing disorders. Sleep Med. 2007;8:681-687.
10.
JulienJYMartinJGErnstP. Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma. J Allergy Clin Immunol. 2009;124:371-376.
11.
ten BrinkeASterkPJMascleeAA. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J. 2005;26:812-818.
12.
CollettPWBrancatisanoAPEngelLA. Upper airway dimensions and movements in bronchial asthma. Am Rev Respir Dis. 1986;133:1143-1149.
13.
YokoeTMinoguchiKMatsuoH. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003;107:1129-1134.
14.
ChanCSWoolcockAJSullivanCE. Nocturnal asthma: role of snoring and obstructive sleep apnea. Am Rev Respir Dis. 1988;137:1502-1504.
15.
LafondCSérièsFLemièreC. Impact of CPAP on asthmatic patients with obstructive sleep apnoea. Eur Respir J. 2007;29:307-311.
16.
GuilleminaultCQuera-SalvaMAPowellN. Nocturnal asthma: snoring, small pharynx and nasal CPAP. Eur Respir J. 1988;1:902-907.
17.
LoubeDIGayPCStrohlKPPackAIWhiteDPCollopNA. Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement. Chest. 1999;115:863-866.
18.
RapoportDM. Methods to stabilize the upper airway using positive pressure. Sleep. 1996;19(9 suppl):S123-S130.
19.
IberCO’BrienCSchluterJDaviesSLeathermanJMahowaldM. Single night studies in obstructive sleep apnea. Sleep. 1991;14:383-385.
20.
McArdleNDouglasNJ. Effect of continuous positive airway pressure on sleep architecture in the sleep apnea-hypopnea syndrome: a randomized controlled trial. Am J Respir Crit Care Med. 2001;164(8 pt 1):1459-1463.
21.
BardwellWAAncoli-IsraelSBerryCCDimsdaleJE. Neuropsychological effects of one-week continuous positive airway pressure treatment in patients with obstructive sleep apnea: a placebo-controlled study. Psychosom Med. 2001;63:579-584.
22.
MontserratJMFerrerMHernandezL. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo. Am J Respir Crit Care Med. 2001;164:608-613.
23.
SannerBMTepelMMarkmannAZidekW. Effect of continuous positive airway pressure therapy on 24-hour blood pressure in patients with obstructive sleep apnea syndrome. Am J Hypertens. 2002;15:251-257.
24.
JavaheriS. Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation. 2000;101:392-397.
25.
HeJKrygerMHZorickFJConwayWRothT. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest. 1988;94:9-14.
26.
BahammamADelaiveKRonaldJManfredaJRoosLKrygerMH. Health care utilization in males with obstructive sleep apnea syndrome two years after diagnosis and treatment. Sleep. 1999;22:740-747.
27.
KribbsNBPackAIKlineLR. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis. 1993;147:887-895.
28.
McArdleNDevereuxGHeidarnejadHEnglemanHMMackayTWDouglasNJ. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999;159(4 pt 1):1108-1114.
29.
KohlerMSmithDTippettVStradlingJR. Predictors of long-term compliance with continuous positive airway pressure. Thorax. 2010;65:829-832.
30.
ChervinRDTheutSBassettiCAldrichMS. Compliance with nasal CPAP can be improved by simple interventions. Sleep. 1997;20:284-289.
